http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 03 Jun 2026 10:00:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/DIAGNOS+to+Present+at+the+Emerging+Growth+Conference+on+June+10%2C+2026/26596881.html <p align="justify"><em>DIAGNOS invites individual and institutional investors, as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference. </em></p> <p align="justify">BROSSARD, Quebec, June 03, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Corporation dedicated to the early detection of eye-related health using Artificial Intelligence (AI) techniques, is pleased to announce that Mr. André Larente, CEO of DIAGNOS, has been invited to present at the Emerging Growth Conference, on June 10, 2026.</p> <p align="justify">This live, interactive online event will give existing shareholders http://www.streetinsider.com/Press+Releases/DIAGNOS+to+Present+at+the+Emerging+Growth+Conference+on+June+10%2C+2026/26596881.html Wed, 03 Jun 2026 10:00:00 -0400 4D4A ADK DGNOF O.02535360 http://www.streetinsider.com/Press+Releases/DIAGNOS+to+Present+at+the+Emerging+Growth+Conference+on+June+10%2C+2026/26596881.html <p align="justify"><em>DIAGNOS invites individual and institutional investors, as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference. </em></p> <p align="justify">BROSSARD, Quebec, June 03, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Corporation dedicated to the early detection of eye-related health using Artificial Intelligence (AI) techniques, is pleased to announce that Mr. André Larente, CEO of DIAGNOS, has been invited to present at the Emerging Growth Conference, on June 10, 2026.</p> <p align="justify">This live, interactive online event will give existing shareholders http://www.streetinsider.com/Press+Releases/DIAGNOS+to+Present+at+the+Emerging+Growth+Conference+on+June+10%2C+2026/26596881.html Wed, 03 Jun 2026 10:00:00 -0400 4D4A ADK DGNOF O.02535360 http://www.streetinsider.com/Press+Releases/DIAGNOS+to+Present+at+the+Emerging+Growth+Conference+on+June+10%2C+2026/26596881.html <p align="justify"><em>DIAGNOS invites individual and institutional investors, as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference. </em></p> <p align="justify">BROSSARD, Quebec, June 03, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Corporation dedicated to the early detection of eye-related health using Artificial Intelligence (AI) techniques, is pleased to announce that Mr. André Larente, CEO of DIAGNOS, has been invited to present at the Emerging Growth Conference, on June 10, 2026.</p> <p align="justify">This live, interactive online event will give existing shareholders http://www.streetinsider.com/Press+Releases/DIAGNOS+to+Present+at+the+Emerging+Growth+Conference+on+June+10%2C+2026/26596881.html Wed, 03 Jun 2026 10:00:00 -0400 4D4A ADK DGNOF O.02535360 http://www.streetinsider.com/Press+Releases/DIAGNOS+to+Present+at+the+Emerging+Growth+Conference+on+June+10%2C+2026/26596881.html <p align="justify"><em>DIAGNOS invites individual and institutional investors, as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference. </em></p> <p align="justify">BROSSARD, Quebec, June 03, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Corporation dedicated to the early detection of eye-related health using Artificial Intelligence (AI) techniques, is pleased to announce that Mr. André Larente, CEO of DIAGNOS, has been invited to present at the Emerging Growth Conference, on June 10, 2026.</p> <p align="justify">This live, interactive online event will give existing shareholders http://www.streetinsider.com/Press+Releases/DIAGNOS+to+Present+at+the+Emerging+Growth+Conference+on+June+10%2C+2026/26596881.html Wed, 03 Jun 2026 10:00:00 -0400 4D4A ADK DGNOF O.02535360 http://www.streetinsider.com/Globe+Newswire/DIAGNOS+to+Present+at+the+Emerging+Growth+Conference+on+June+10%2C+2026/26596881.html <p align="justify"><em>DIAGNOS invites individual and institutional investors, as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference. </em></p> <p align="justify">BROSSARD, Quebec, June 03, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Corporation dedicated to the early detection of eye-related health using Artificial Intelligence (AI) techniques, is pleased to announce that Mr. André Larente, CEO of DIAGNOS, has been invited to present at the Emerging Growth Conference, on June 10, 2026.</p> <p align="justify">This live, interactive online event will give existing shareholders http://www.streetinsider.com/Globe+Newswire/DIAGNOS+to+Present+at+the+Emerging+Growth+Conference+on+June+10%2C+2026/26596881.html Wed, 03 Jun 2026 10:00:00 -0400 4D4A ADK DGNOF O.02535360 http://www.streetinsider.com/Globe+Newswire/DIAGNOS+to+Present+at+the+Emerging+Growth+Conference+on+June+10%2C+2026/26596881.html <p align="justify"><em>DIAGNOS invites individual and institutional investors, as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference. </em></p> <p align="justify">BROSSARD, Quebec, June 03, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Corporation dedicated to the early detection of eye-related health using Artificial Intelligence (AI) techniques, is pleased to announce that Mr. André Larente, CEO of DIAGNOS, has been invited to present at the Emerging Growth Conference, on June 10, 2026.</p> <p align="justify">This live, interactive online event will give existing shareholders http://www.streetinsider.com/Globe+Newswire/DIAGNOS+to+Present+at+the+Emerging+Growth+Conference+on+June+10%2C+2026/26596881.html Wed, 03 Jun 2026 10:00:00 -0400 4D4A ADK DGNOF O.02535360 http://www.streetinsider.com/Globe+Newswire/DIAGNOS+to+Present+at+the+Emerging+Growth+Conference+on+June+10%2C+2026/26596881.html <p align="justify"><em>DIAGNOS invites individual and institutional investors, as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference. </em></p> <p align="justify">BROSSARD, Quebec, June 03, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Corporation dedicated to the early detection of eye-related health using Artificial Intelligence (AI) techniques, is pleased to announce that Mr. André Larente, CEO of DIAGNOS, has been invited to present at the Emerging Growth Conference, on June 10, 2026.</p> <p align="justify">This live, interactive online event will give existing shareholders http://www.streetinsider.com/Globe+Newswire/DIAGNOS+to+Present+at+the+Emerging+Growth+Conference+on+June+10%2C+2026/26596881.html Wed, 03 Jun 2026 10:00:00 -0400 4D4A ADK DGNOF O.02535360 http://www.streetinsider.com/Globe+Newswire/DIAGNOS+to+Present+at+the+Emerging+Growth+Conference+on+June+10%2C+2026/26596881.html <p align="justify"><em>DIAGNOS invites individual and institutional investors, as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference. </em></p> <p align="justify">BROSSARD, Quebec, June 03, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Corporation dedicated to the early detection of eye-related health using Artificial Intelligence (AI) techniques, is pleased to announce that Mr. André Larente, CEO of DIAGNOS, has been invited to present at the Emerging Growth Conference, on June 10, 2026.</p> <p align="justify">This live, interactive online event will give existing shareholders http://www.streetinsider.com/Globe+Newswire/DIAGNOS+to+Present+at+the+Emerging+Growth+Conference+on+June+10%2C+2026/26596881.html Wed, 03 Jun 2026 10:00:00 -0400 4D4A ADK DGNOF O.02535360 http://www.streetinsider.com/Press+Releases/DIAGNOS+Announces+Amendment+to+Convertible+Debentures/26487921.html <p align="justify">BROSSARD, Quebec, May 13, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company dedicated to the early detection of critical health issues using advanced Artificial Intelligence (<em>AI</em>) techniques, announces that it intends to extend the maturity date of an aggregate amount of $300,000 of unsecured convertible debentures (each, a Debenture) issued as part of a non-brokered private placement of units initially announced on May 18, 2023, and subsequently amended on May 18, 2025 (pleaser refer to the press release dated May 20, 2025). The amended maturity date set http://www.streetinsider.com/Press+Releases/DIAGNOS+Announces+Amendment+to+Convertible+Debentures/26487921.html Wed, 13 May 2026 19:00:00 -0400 4D4A A.36078215 ADK DGNOF O.02535360 O.02555813 http://www.streetinsider.com/Press+Releases/DIAGNOS+Announces+Amendment+to+Convertible+Debentures/26487921.html <p align="justify">BROSSARD, Quebec, May 13, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company dedicated to the early detection of critical health issues using advanced Artificial Intelligence (<em>AI</em>) techniques, announces that it intends to extend the maturity date of an aggregate amount of $300,000 of unsecured convertible debentures (each, a Debenture) issued as part of a non-brokered private placement of units initially announced on May 18, 2023, and subsequently amended on May 18, 2025 (pleaser refer to the press release dated May 20, 2025). The amended maturity date set http://www.streetinsider.com/Press+Releases/DIAGNOS+Announces+Amendment+to+Convertible+Debentures/26487921.html Wed, 13 May 2026 19:00:00 -0400 4D4A A.36078215 ADK DGNOF O.02535360 O.02555813 http://www.streetinsider.com/Press+Releases/DIAGNOS+Announces+Amendment+to+Convertible+Debentures/26487921.html <p align="justify">BROSSARD, Quebec, May 13, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company dedicated to the early detection of critical health issues using advanced Artificial Intelligence (<em>AI</em>) techniques, announces that it intends to extend the maturity date of an aggregate amount of $300,000 of unsecured convertible debentures (each, a Debenture) issued as part of a non-brokered private placement of units initially announced on May 18, 2023, and subsequently amended on May 18, 2025 (pleaser refer to the press release dated May 20, 2025). The amended maturity date set http://www.streetinsider.com/Press+Releases/DIAGNOS+Announces+Amendment+to+Convertible+Debentures/26487921.html Wed, 13 May 2026 19:00:00 -0400 4D4A A.36078215 ADK DGNOF O.02535360 O.02555813 http://www.streetinsider.com/Press+Releases/DIAGNOS+Announces+Amendment+to+Convertible+Debentures/26487921.html <p align="justify">BROSSARD, Quebec, May 13, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company dedicated to the early detection of critical health issues using advanced Artificial Intelligence (<em>AI</em>) techniques, announces that it intends to extend the maturity date of an aggregate amount of $300,000 of unsecured convertible debentures (each, a Debenture) issued as part of a non-brokered private placement of units initially announced on May 18, 2023, and subsequently amended on May 18, 2025 (pleaser refer to the press release dated May 20, 2025). The amended maturity date set http://www.streetinsider.com/Press+Releases/DIAGNOS+Announces+Amendment+to+Convertible+Debentures/26487921.html Wed, 13 May 2026 19:00:00 -0400 4D4A A.36078215 ADK DGNOF O.02535360 O.02555813 http://www.streetinsider.com/Press+Releases/DIAGNOS+Announces+Amendment+to+Convertible+Debentures/26487921.html <p align="justify">BROSSARD, Quebec, May 13, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company dedicated to the early detection of critical health issues using advanced Artificial Intelligence (<em>AI</em>) techniques, announces that it intends to extend the maturity date of an aggregate amount of $300,000 of unsecured convertible debentures (each, a Debenture) issued as part of a non-brokered private placement of units initially announced on May 18, 2023, and subsequently amended on May 18, 2025 (pleaser refer to the press release dated May 20, 2025). The amended maturity date set http://www.streetinsider.com/Press+Releases/DIAGNOS+Announces+Amendment+to+Convertible+Debentures/26487921.html Wed, 13 May 2026 19:00:00 -0400 4D4A A.36078215 ADK DGNOF O.02535360 O.02555813 http://www.streetinsider.com/Press+Releases/DIAGNOS+Announces+Amendment+to+Convertible+Debentures/26487921.html <p align="justify">BROSSARD, Quebec, May 13, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company dedicated to the early detection of critical health issues using advanced Artificial Intelligence (<em>AI</em>) techniques, announces that it intends to extend the maturity date of an aggregate amount of $300,000 of unsecured convertible debentures (each, a Debenture) issued as part of a non-brokered private placement of units initially announced on May 18, 2023, and subsequently amended on May 18, 2025 (pleaser refer to the press release dated May 20, 2025). The amended maturity date set http://www.streetinsider.com/Press+Releases/DIAGNOS+Announces+Amendment+to+Convertible+Debentures/26487921.html Wed, 13 May 2026 19:00:00 -0400 4D4A A.36078215 ADK DGNOF O.02535360 O.02555813 http://www.streetinsider.com/Globe+Newswire/DIAGNOS+Announces+Amendment+to+Convertible+Debentures/26487921.html <p align="justify">BROSSARD, Quebec, May 13, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company dedicated to the early detection of critical health issues using advanced Artificial Intelligence (<em>AI</em>) techniques, announces that it intends to extend the maturity date of an aggregate amount of $300,000 of unsecured convertible debentures (each, a Debenture) issued as part of a non-brokered private placement of units initially announced on May 18, 2023, and subsequently amended on May 18, 2025 (pleaser refer to the press release dated May 20, 2025). The amended maturity date set http://www.streetinsider.com/Globe+Newswire/DIAGNOS+Announces+Amendment+to+Convertible+Debentures/26487921.html Wed, 13 May 2026 19:00:00 -0400 4D4A A.36078215 ADK DGNOF O.02535360 O.02555813 http://www.streetinsider.com/Globe+Newswire/DIAGNOS+Announces+Amendment+to+Convertible+Debentures/26487921.html <p align="justify">BROSSARD, Quebec, May 13, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company dedicated to the early detection of critical health issues using advanced Artificial Intelligence (<em>AI</em>) techniques, announces that it intends to extend the maturity date of an aggregate amount of $300,000 of unsecured convertible debentures (each, a Debenture) issued as part of a non-brokered private placement of units initially announced on May 18, 2023, and subsequently amended on May 18, 2025 (pleaser refer to the press release dated May 20, 2025). The amended maturity date set http://www.streetinsider.com/Globe+Newswire/DIAGNOS+Announces+Amendment+to+Convertible+Debentures/26487921.html Wed, 13 May 2026 19:00:00 -0400 4D4A A.36078215 ADK DGNOF O.02535360 O.02555813 http://www.streetinsider.com/Globe+Newswire/DIAGNOS+Announces+Amendment+to+Convertible+Debentures/26487921.html <p align="justify">BROSSARD, Quebec, May 13, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company dedicated to the early detection of critical health issues using advanced Artificial Intelligence (<em>AI</em>) techniques, announces that it intends to extend the maturity date of an aggregate amount of $300,000 of unsecured convertible debentures (each, a Debenture) issued as part of a non-brokered private placement of units initially announced on May 18, 2023, and subsequently amended on May 18, 2025 (pleaser refer to the press release dated May 20, 2025). The amended maturity date set http://www.streetinsider.com/Globe+Newswire/DIAGNOS+Announces+Amendment+to+Convertible+Debentures/26487921.html Wed, 13 May 2026 19:00:00 -0400 4D4A A.36078215 ADK DGNOF O.02535360 O.02555813 http://www.streetinsider.com/Globe+Newswire/DIAGNOS+Announces+Amendment+to+Convertible+Debentures/26487921.html <p align="justify">BROSSARD, Quebec, May 13, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company dedicated to the early detection of critical health issues using advanced Artificial Intelligence (<em>AI</em>) techniques, announces that it intends to extend the maturity date of an aggregate amount of $300,000 of unsecured convertible debentures (each, a Debenture) issued as part of a non-brokered private placement of units initially announced on May 18, 2023, and subsequently amended on May 18, 2025 (pleaser refer to the press release dated May 20, 2025). The amended maturity date set http://www.streetinsider.com/Globe+Newswire/DIAGNOS+Announces+Amendment+to+Convertible+Debentures/26487921.html Wed, 13 May 2026 19:00:00 -0400 4D4A A.36078215 ADK DGNOF O.02535360 O.02555813 http://www.streetinsider.com/Globe+Newswire/DIAGNOS+Announces+Amendment+to+Convertible+Debentures/26487921.html <p align="justify">BROSSARD, Quebec, May 13, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company dedicated to the early detection of critical health issues using advanced Artificial Intelligence (<em>AI</em>) techniques, announces that it intends to extend the maturity date of an aggregate amount of $300,000 of unsecured convertible debentures (each, a Debenture) issued as part of a non-brokered private placement of units initially announced on May 18, 2023, and subsequently amended on May 18, 2025 (pleaser refer to the press release dated May 20, 2025). The amended maturity date set http://www.streetinsider.com/Globe+Newswire/DIAGNOS+Announces+Amendment+to+Convertible+Debentures/26487921.html Wed, 13 May 2026 19:00:00 -0400 4D4A A.36078215 ADK DGNOF O.02535360 O.02555813 http://www.streetinsider.com/Globe+Newswire/DIAGNOS+Announces+Amendment+to+Convertible+Debentures/26487921.html <p align="justify">BROSSARD, Quebec, May 13, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company dedicated to the early detection of critical health issues using advanced Artificial Intelligence (<em>AI</em>) techniques, announces that it intends to extend the maturity date of an aggregate amount of $300,000 of unsecured convertible debentures (each, a Debenture) issued as part of a non-brokered private placement of units initially announced on May 18, 2023, and subsequently amended on May 18, 2025 (pleaser refer to the press release dated May 20, 2025). The amended maturity date set http://www.streetinsider.com/Globe+Newswire/DIAGNOS+Announces+Amendment+to+Convertible+Debentures/26487921.html Wed, 13 May 2026 19:00:00 -0400 4D4A A.36078215 ADK DGNOF O.02535360 O.02555813 http://www.streetinsider.com/Press+Releases/DIAGNOS+Provides+an+Update+on+Sales+and+Regulatory+Activities+for+CARA/26288194.html <p align="justify">BROSSARD, Quebec, April 08, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company dedicated to the early detection of eye-related health using Artificial Intelligence (AI) techniques, is pleased to provide an update to the press release dated January 13, 2026 on the regulatory pathway for the future version of its flagship product CARA, which incorporates eye-related disease detection algorithms, and April 1, 2026 announcement regarding U.S. establishment registration renewal and the continued U.S. commercialization status of the legacy version of CARA.</p> <ul type="disc"><li style="margin-bottom:7.5pt; text-align:justify;">Saudi Arabia: http://www.streetinsider.com/Press+Releases/DIAGNOS+Provides+an+Update+on+Sales+and+Regulatory+Activities+for+CARA/26288194.html Wed, 08 Apr 2026 12:14:00 -0400 4D4A A.06822034 A.17150087 A.36078215 ADK DGNOF O.02535360 O.02555813 O.20026344 O.49223070 http://www.streetinsider.com/Press+Releases/DIAGNOS+Provides+an+Update+on+Sales+and+Regulatory+Activities+for+CARA/26288194.html <p align="justify">BROSSARD, Quebec, April 08, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company dedicated to the early detection of eye-related health using Artificial Intelligence (AI) techniques, is pleased to provide an update to the press release dated January 13, 2026 on the regulatory pathway for the future version of its flagship product CARA, which incorporates eye-related disease detection algorithms, and April 1, 2026 announcement regarding U.S. establishment registration renewal and the continued U.S. commercialization status of the legacy version of CARA.</p> <ul type="disc"><li style="margin-bottom:7.5pt; text-align:justify;">Saudi Arabia: http://www.streetinsider.com/Press+Releases/DIAGNOS+Provides+an+Update+on+Sales+and+Regulatory+Activities+for+CARA/26288194.html Wed, 08 Apr 2026 12:14:00 -0400 4D4A A.06822034 A.17150087 A.36078215 ADK DGNOF O.02535360 O.02555813 O.20026344 O.49223070 http://www.streetinsider.com/Press+Releases/DIAGNOS+Provides+an+Update+on+Sales+and+Regulatory+Activities+for+CARA/26288194.html <p align="justify">BROSSARD, Quebec, April 08, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company dedicated to the early detection of eye-related health using Artificial Intelligence (AI) techniques, is pleased to provide an update to the press release dated January 13, 2026 on the regulatory pathway for the future version of its flagship product CARA, which incorporates eye-related disease detection algorithms, and April 1, 2026 announcement regarding U.S. establishment registration renewal and the continued U.S. commercialization status of the legacy version of CARA.</p> <ul type="disc"><li style="margin-bottom:7.5pt; text-align:justify;">Saudi Arabia: http://www.streetinsider.com/Press+Releases/DIAGNOS+Provides+an+Update+on+Sales+and+Regulatory+Activities+for+CARA/26288194.html Wed, 08 Apr 2026 12:14:00 -0400 4D4A A.06822034 A.17150087 A.36078215 ADK DGNOF O.02535360 O.02555813 O.20026344 O.49223070 http://www.streetinsider.com/Press+Releases/DIAGNOS+Provides+an+Update+on+Sales+and+Regulatory+Activities+for+CARA/26288194.html <p align="justify">BROSSARD, Quebec, April 08, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company dedicated to the early detection of eye-related health using Artificial Intelligence (AI) techniques, is pleased to provide an update to the press release dated January 13, 2026 on the regulatory pathway for the future version of its flagship product CARA, which incorporates eye-related disease detection algorithms, and April 1, 2026 announcement regarding U.S. establishment registration renewal and the continued U.S. commercialization status of the legacy version of CARA.</p> <ul type="disc"><li style="margin-bottom:7.5pt; text-align:justify;">Saudi Arabia: http://www.streetinsider.com/Press+Releases/DIAGNOS+Provides+an+Update+on+Sales+and+Regulatory+Activities+for+CARA/26288194.html Wed, 08 Apr 2026 12:14:00 -0400 4D4A A.06822034 A.17150087 A.36078215 ADK DGNOF O.02535360 O.02555813 O.20026344 O.49223070 http://www.streetinsider.com/Press+Releases/DIAGNOS+Provides+an+Update+on+Sales+and+Regulatory+Activities+for+CARA/26288194.html <p align="justify">BROSSARD, Quebec, April 08, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company dedicated to the early detection of eye-related health using Artificial Intelligence (AI) techniques, is pleased to provide an update to the press release dated January 13, 2026 on the regulatory pathway for the future version of its flagship product CARA, which incorporates eye-related disease detection algorithms, and April 1, 2026 announcement regarding U.S. establishment registration renewal and the continued U.S. commercialization status of the legacy version of CARA.</p> <ul type="disc"><li style="margin-bottom:7.5pt; text-align:justify;">Saudi Arabia: http://www.streetinsider.com/Press+Releases/DIAGNOS+Provides+an+Update+on+Sales+and+Regulatory+Activities+for+CARA/26288194.html Wed, 08 Apr 2026 12:14:00 -0400 4D4A A.06822034 A.17150087 A.36078215 ADK DGNOF O.02535360 O.02555813 O.20026344 O.49223070